$LLY positioning for next leg up. Eli Lilly showing momentum signals worth watching for entry. GLP-1 franchise continues to drive institutional accumulation. Risk/reward favors longs here if broader pharma sector holds support.
Penafian: Berisi opini pihak ketiga. Bukan nasihat keuangan. Dapat berisi konten bersponsor.Baca S&K.